Expanded coverage for oral drugs used with chemotherapy may shift billing
Just-released billing rules for the expanded coverage of an oral version of a three-drug regimen used to fight nausea and vomiting for patients receiving certain types of chemotherapy drugs may shift billing and payment for those drugs — and the associated revenue — from your practice.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.